Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity

被引:5
作者
Rath, Susann [1 ]
Schepmann, Dirk [1 ]
Wuensch, Bernhard [1 ,2 ]
机构
[1] Univ Munster, Inst Pharmazeut & Med Chem, Corrensstr 48, D-48149 Munster, Germany
[2] Westfal Wilhelms Univ Munster, Cells In Mot Cluster Excellence EXC CiM 1003, Munster, Germany
关键词
NMDA receptor; GluN2B ligands; 3-Benzazepines; Structure affinity relationships; Selectivity; NMDA RECEPTOR ANTAGONISTS; IONOTROPIC GLUTAMATE RECEPTORS; D-ASPARTATE RECEPTOR; SELECTIVE NMDA; BIOLOGICAL EVALUATION; IFENPRODIL; NR2B; DIVERSITY;
D O I
10.1016/j.bmc.2017.07.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since overactivation of NMDA receptors is associated with neurodegenerative disorders, the design and development of subunit-selective NMDA receptor antagonists are of great interest. In order to avoid the formation of quinone-like intermediates as starting point for degradation the benzylic OH group of the lead compounds 2 was replaced by an electron rich vinyl or homologous hydroxymethyl moiety. The Bi(OTf)(3) catalyzed intramolecular Friedel-Crafts alkylation of 9a represents the key step in the synthesis of 1-vinyl substituted tetrahydro-3-benzazepine 10. Ozonolysis of 10 and subsequent reduction led to the hydroxymethyl derivative 14. The GluN2B affinities of the methyl ethers 2a, 3a and 4a and phenols 2b and 3b are very similar, respectively. It can be concluded that the ifenprodil binding site of GluN2B subunit containing NMDA receptors well tolerates a vinyl or hydroxymethyl moiety instead of the benzylic OH group. However, the selectivity has to improved, since the sigma(1) affinity of the new ligands is higher than their GluN2B affinity. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:5365 / 5372
页数:8
相关论文
共 14 条
  • [1] Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies
    Szermerski, Marina
    Boergel, Frederik
    Schepmann, Dirk
    Haider, Ahmed
    Betzel, Thomas
    Ametamey, Simon M.
    Wuensch, Bernhard
    CHEMMEDCHEM, 2018, 13 (10) : 1058 - 1068
  • [2] Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold
    Boergel, Frederik
    Galla, Fabian
    Lehmkuhl, Kirstin
    Schepmann, Dirk
    Ametamey, Simon M.
    Wuensch, Bernhard
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 172 : 214 - 222
  • [3] Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold
    Dey, Sougata
    Schepmann, Dirk
    Wuensch, Bernhard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (03) : 889 - 893
  • [4] Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists
    Wagner, Marina
    Schepmann, Dirk
    Ametamey, Simon M.
    Wuensch, Bernhard
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (16) : 3559 - 3567
  • [5] Replacement of the Benzylpiperidine Moiety with Fluorinated Phenylalkyl Side Chains for the Development of GluN2B Receptor Ligands
    Thum, Simone
    Schepmann, Dirk
    Kalinin, Dmitrii V.
    Ametamey, Simon M.
    Wuensch, Bernhard
    CHEMMEDCHEM, 2018, 13 (23) : 2522 - 2529
  • [6] Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold
    Ritter, Nadine
    Korff, Marvin
    Markus, Alexander
    Schepmann, Dirk
    Seebohm, Guiscard
    Schreiber, Julian A.
    Wuensch, Bernhard
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 : 1 - 13
  • [7] Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors
    Dey, Sougata
    Temme, Louisa
    Schreiber, Julian A.
    Schepmann, Dirk
    Frehland, Bastian
    Lehmkuhl, Kirstin
    Strutz-Seebohm, Nathalie
    Seebohm, Guiscard
    Wuensch, Bernhard
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 552 - 564
  • [8] Negative allosteric modulators of NMDA receptors with GluN2B subunit: Alanine-derived benzoxazolone bioisosteres of 2-methyl-3-benzazepine-1,7-diols
    Markus, Alexander
    Frehland, Bastian
    Schepmann, Dirk
    Wuensch, Bernhard
    ARCHIV DER PHARMAZIE, 2022, 355 (09)
  • [9] Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol - starting point for PET tracer development
    Korff, Marvin
    Steigerwald, Ruben
    Bechthold, Elena
    Schepmann, Dirk
    Schreiber, Julian A.
    Meuth, Sven G.
    Seebohm, Guiscard
    Wuensch, Bernhard
    BIOLOGICAL CHEMISTRY, 2023, 404 (04) : 279 - 289
  • [10] Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (11C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors
    Lisheng Cai
    Jeih-San Liow
    Cheryl L. Morse
    Sanjay Telu
    Riley Davies
    Lester S. Manly
    Sami S. Zoghbi
    Frederick T. Chin
    Robert B. Innis
    Victor W. Pike
    EJNMMI Research, 13